/
CRISPR Therapeutics AG
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
Mentions
1 mention · latest on 9 Oct 2026
See which tracked investors hold CRISPR Therapeutics AG →Ownership and position changes on OwnershipTrace
| Investment Opportunities: Q4 Outlook | - | 9 Oct 2026 |